Indrayani Biotech consolidated net profit rises 405.77% in the September 2022 quarter
Sales rise 183.16% to Rs 42.05 crore
Net profit of Indrayani Biotech rose 405.77% to Rs 5.26 crore in the quarter ended September 2022 as against Rs 1.04 crore during the previous quarter ended September 2021. Sales rose 183.16% to Rs 42.05 crore in the quarter ended September 2022 as against Rs 14.85 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales42.0514.85 183 OPM %12.3711.04 -PBDT6.011.15 423 PBT5.261.04 406 NP5.261.04 406Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 15 2022 | 2:49 PM IST